2Weiser MA, Cabanillas M, Vu K, et al. Diagnostic evaluation of patients with a high suspicion of malignancy: comorbidities and clinical predictors of cancer [ J ]. Am J Med Sci, 2005, 330 (1): 11-18. 被引量：1
4Gungor T, Kanat-PektasM, SucakA, et al. The role of thrombo- cytosis in prognostic evaluation of epithelial ovarian tumors [ J ]. Arch Gyoecol Obstet, 2009, 279 (1) : 53 -56. 被引量：1
5Yu D, Liu B, Zhang L, et al. Platelet count predicts prognosis in operable non-small cell lung cancer [ J ]. Experim Therap Med, 2013, 5 (5): 1351-1354. 被引量：1
6Wan S, Lai Y, Myers RE, et al. Preoperative platelet count as- sociates with survival and distant metastasis in surgically resected colorectal cancer patients? [ J]. J Gastrointest Cancer, 2013, 44 (3) : 293 - 304. 被引量：1
7Shimada Y, Kato T, Ogami K, et al. Production of thrombopoie- tin (TPO) by rat hepatocytes and hepatoma cell lines [ J]. Exp Hematol, 1995, 23:1388 - 1396. 被引量：1
8Furuhashi M, Miyabe Y, Oda H. A case of thrombopoietin-pm- ducing ovarian carcinoma confirmed by immunohistochemistry [J]. Gynecol Oncol, 1999, 74: 278-281. 被引量：1
9Ciurea SO, Hoffman R. Cytokines for the treatment of thrombocy- tooenia [J]. Semin Hematol. 2007. 44: 166-182. 被引量：1
10Tas F, Oguz H, Argon A, et al. Thevalue of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma : serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma [ J ]. Med Oncol, 2005, 22:241-246. 被引量：1
二级参考文献36
1Tsuruo T,Fujita N.Platelet aggregation in the formation of tumor metastasis[J].Proc Jpn Acad Ser B Phys Biol Sci,2008,84(6):189-198. 被引量：1
2Borsig L.Antimetastatic activities of modified heparins; selectin inhibition by heparin attenuates metastasis[J].Semin Thromb Hemost,2007,33(5):540-546. 被引量：1
3Ladwig RJ,Schon MP,Boehncke WH.P-selectin:a therapeutic target for cardiovascular disorders,inflammation and tumour metastasis(J].Expert Opin Ther Targets,2007,11(8):1103-1117. 被引量：1
4Varon D,Shai E.Role of platelet-derived microparticles in angiogenesis and tumor progression[J].Discov Mod,2009,8(43):237-241. 被引量：1
5Helley D,Banu E,Bouziane A,et al.Platelet microparticles:a potential predictive factor of survival in hnnone-refractory prostate cancer patients treated with docetaxel-based chemotherapy[J].Eur Urol,2009,56(3):479484. 被引量：1
6Wang Z,Ahmad A,Li Y,et al.Emerging rules of PDGF-D signaling pathway in tumor development and progression[J].Biochim Biophys Acts,2010,1806(1):122-130. 被引量：1
7Stocking KL,Jones JC,Everds NE,et al.Use of low-molecularweight heparin to decrease mortality in mice after intracardiac injection of tumor cells[J].Comp Med,2009,59(1):37-45. 被引量：1
8Cohen SA,Trikha M,Mascelli MA.Potential future clinical applications for the GP II b/]I[a antagonist,abciximab in thrombosis,vascular and oncologicalindications[J].Pathol Oncol Res,2000,6(3):163-174. 被引量：1
9Amirkhosravi A,Mousa SA,Amaya M,et al.Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GP U b/ ill a antagnist XV454[J].Thromb Haemost,2003,90(3):549-54. 被引量：1
10Marathe DD,Buffone A Jr,Chandrasekaran EV,et al.Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins[J].Blood,2010,115(6):1303-1312. 被引量：1
2Sierko E, Wojtukiweicz MZ. Platelets and angiogenesis inmalignancy [J]. Semin Thromb Hemost, 2004,30 ( 1): 95-108. 被引量：1
3Stone RL, Nick AM, McNeish IA,et al. Paraneoplasticthrombocytosis in ovarian cancer [J]. N Eng J Med,2012,366 (7): 610-618. 被引量：1
4Gay LJ,Felding-Habermann B. Contribution of plateletsto tumour metastasis [J]. Nat Rev Cancer,2011,11 ( 2 ):123-134. 被引量：1
5Holmes MD, Chen WY, Li Y, et al. Aspirin intake andsurvival after breast cancer [J]. J Clin Oncol,2010,28(9):1467-1472. 被引量：1
6Sasaki K, Kawai K, Tsuno NH, et al. Impact ofpreoperative thrombocytosis on the survival of patientswith primary colorectal cancer [J]. World J Surg,2012,36(1 ): 192-200. 被引量：1
7Ferroni P, Spila A, D,Alssandro R, et al. Plateletactivation and vascular endothelial growth factor 165release in hepatocellular cancer [J]. Clin Chim Acta,2011,412 (5/6): 450-454. 被引量：1
